MedPath

Outcome of Idiopathic Macular Hole

Completed
Conditions
Idiopathic Macular Hole
Registration Number
NCT00941291
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Brief Summary

The purpose of this study is to evaluate the role of cataract surgery and cystoid macular edema (CME) on reopening of idiopathic macular holes (IMH).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
135
Inclusion Criteria
  • Patients with with stage 2, 3, or 4 Idiopathic Macular Hole after successful Idiopathic Macular Hole repair
Exclusion Criteria
  • All patients without stage 2, 3, or 4 Idiopathic Macular Hole repair

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Long-term outcome of idiopathic macular hole surgery37 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ophthalmology Unit CHU Dijon

🇫🇷

Dijon, Burgundy, France

© Copyright 2025. All Rights Reserved by MedPath